New draft guidance published by NICE – the National Institute for Health and Care Excellence recommends the use of the digital technology ‘QbTest’ to help diagnose ADHD in children and young people.
QbTest is a technology that supports objective assessment within the ADHD diagnosis pathway, helping to supplement clinical judgement by measuring a patient’s attention, impulsivity, and motor activity – the three are core symptoms of ADHD.
Developed by company Qbtech, the technology has been rolled out across England from 2020 as part of our Focus ADHD national programme, led by the 15 local networks.
A total of 79 NHS trusts have adopted the technology since 2020 – around three quarters of all trusts that provide ADHD diagnosis – benefiting more than 70,000 young people.
Evaluation of the technology within the East Midlands showed it can help speed up the time from assessment to diagnosis reduced by an average of 153 days.
This increases staff capacity by reducing the number of appointments needed for diagnosis, and since April 2020 an estimated 20,439 NHS appointments have been freed up across England.
This has saved the NHS an estimated £24m, enabling redirection of resources to other parts of the ADHD care pathway, and is a great example of local change having a national impact.
NICE’s draft guidelines on the diagnosis and management of ADHD were published on 16 July; a consultation is underway and comments can be submitted up to 6 August 2024.
Find out more about the Health Innovation Network’s Focus ADHD national programme and meet Tony Doyle, Managing Director of Qbtech in our ‘Meet the Innovator’ interview.
Angie Doshani, is founder of JanamApp and Consultant Obstetrician and Gynaecologist at University Hospitals of Leicester NHS Trust. JanamApp is a ground-breaking solution addressing the disparities in pregnancy outcomes faced by South Asian women, who experience a 1.8 times higher risk compared to their white counterparts. The challenges of some women from this demographic include [...]
Lesley Bull, a South London GP and our 1000th delegate chats to Lois-Hooper Ainsworth, Programme Coordinator on the National Polypharmacy Programme, about why she registered for the Health Innovation Network Polypharmacy Action Learning Set, what she got out of it and why other GPs should attend. Lesley Bull So, Lesley, could you tell [...]
Jo Barosa is Account Director at Qbtech UK. Qbtech is a market leading provider of innovative objective tests for assessing and treating ADHD, changing the landscape of ADHD care. Driven by its mission to improve the lives of people with ADHD, Qbtech supports by providing digital and clinical solutions to improve clinical decision making, service [...]